Examining ultrafine particle pollution and lung cancer risk in a large, diverse cohort.

Author:

Bookstein Arthur1,Po Justine1,Cheng Iona2,Wu Anna H.3,Larson Timothy V.4,Park Lani5,Wu Jun6,Shariff-Marco Salma7,Inamdar Pushkar8,Setiawan Veronica Wendy3,DeRouen Mindy9,Gomez Scarlett L.10,Le Marchand Loic11,Stram Daniel1,Samet Jonathan12,Ritz Beate13,Fruin Scott A.1

Affiliation:

1. Keck School of Medicine of University of Southern California, Los Angeles, CA

2. University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

3. University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA

4. Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA

5. Population Sciences in the Pacific Program, University of Hawaiʻi Cancer Center, Honolulu, HI

6. Division of Occupational and Environmental Medicine, University of California, Irvine, Irvine, CA

7. Greater Bay Area Cancer Registry, Fremont, CA

8. Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA

9. Helen Diller Family Comprehensive Cancer Center University of California San Francisco, San Francisco, CA

10. Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA

11. University of Hawai‘i Cancer Center – University of Hawai‘i at Mānoa, Honolulu, HI

12. Colorado School of Public Health, Denver, CO

13. University of California, Los Angeles Fielding School of Public Health, Los Angeles, CA

Abstract

8532 Background: Health effects associated with particles less than 2.5 μm in diameter (PM2.5) have been well studied, leading to the establishment of air quality standards and routine monitoring. Additionally, there is growing experimental evidence that ultrafine particles (UFPs), defined as particles less than 0.1µm in diameter, may adversely affect lung health, eliciting greater injury than larger particles due to deeper penetration into airways and longer retention in the lung parenchyma. Only two epidemiological studies have investigated this topic, finding no associations between ambient UFPs and respiratory mortality or overall lung cancer incidence respectively. Given the limited epidemiologic investigation of UFPs and lung cancer, we examined the association between airport-related UFPs and lung cancer incidence in a large, racially and ethnically diverse cohort. Methods: We estimated airport-related UFP exposure for 71,387 participants of the Multiethnic Cohort, who lived within a 53 km×43 km grid area around the Los Angeles International Airport (LAX) from date of cohort entry (1993-1996) through December 31, 2013. Cox proportional hazards regression was used, with calendar month/year as the time variable, to examine associations between UFP exposure and lung cancer risk adjusting for demographics, lifetime smoking, neighborhood socioeconomic status, occupation and lifestyle factors. Subgroup analyses were conducted by racial and ethnic groups, lung cancer histology, and smoking status. Co-pollutant models were run to mutually adjust for other traffic-related air pollutants. Results: A per unit increase in the interquartile range (IQR) of airport-related UFP exposure was not associated with lung cancer risk overall [HR = 1.01, 95% CI: 0.97-1.05] or by race and ethnicity. UFP exposure was suggestive of a positive association with risk of lung squamous cell carcinoma (SCC) [HR per IQR = 1.08, 95% CI: 1.00-1.17]. No associations were observed for other histologies [Phet for histology = .05]. UFP exposure was associated with an increased SCC risk among current smokers [HR = 1.11, 95% CI: 1.01-1.22] but not among never or past smokers [Phet for smoking = 0.51]. Conclusions: This study suggests a possible association between airport-related UFP exposure and risk of SCC. These results may be explained by previous studies finding that UFPs activate genes involved in oxidative damage, TNF-α signaling via NF-κB, and secretion of inflammatory and cardiopulmonary disease biomarkers. These findings warrant further investigation in large epidemiologic cohorts.

Funder

U.S. National Institutes of Health

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3